checkAd
    Startseite > Aktien > Medacta Group > Nachrichten
    Medacta Group Aktie
    115,70
     
    EUR
    +1,58 %
    +1,80 EUR
    Letzter Kurs 22:58:01 Lang & Schwarz
    114,80
     
    EUR
    42 STK
    Geldkurs 22:58:01
    116,60
     
    EUR
    42 STK
    Briefkurs 22:58:01
    ISIN: CH0468525222 · WKN: A2PFTD · Schweiz

    Neueste Nachrichten

    Medacta announces the 10th M.O.R.E. International Symposium in Lugano, Switzerland, celebrating its 25th anniversary worldwide
    11.04.24 · EQS Group AG · Medacta Group
    Medacta publishes 2024 Annual General Meeting invitation
    09.04.24 · EQS Group AG · Medacta Group
    Medacta Group SA Achieves 19.5% Revenue Growth, 27.9% EBITDA Margin in FY 2023
    13.03.24 · wO Newsflash · Medacta Group
    Medacta Group SA: Medacta Group SA reports robust revenue growth of 19.5% at constant currency and adjusted EBITDA1 margin 26.3%, or 27.9% at constant currency in FY 2023
    13.03.24 · EQS Group AG · Medacta Group
    Medacta to Feature GMK SpheriKA and Innovative Personalized Solutions at AAOS 2024
    12.02.24 · EQS Group AG · Medacta Group
    Medacta Group SA: Medacta Group SA revenues up +19.5% at constant currency1 exceeding the milestone of 500Mln € in FY 2023
    02.02.24 · EQS Group AG · Medacta Group
    Medacta’s QUADRA-H hip stem achieves 13A* exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP)
    08.01.24 · EQS Group AG · Medacta Group
    A new clinical study highlights efficiency in spine surgery of NextAR Spine, augmented reality surgical application
    14.12.23 · EQS Group AG · Medacta Group
    Medacta further expands in Rancate, Switzerland, doubling its production capability to support the future growth
    29.11.23 · EQS Group AG · Medacta Group
    Medacta Announces the Launch of GMK SpheriKA, the World's First Knee Implant Optimized for Kinematic Alignment (KA)
    30.10.23 · EQS Group AG · Medacta Group
    A new study confirms the accuracy of NextAR Shoulder, Medacta’s augmented reality surgical application
    12.10.23 · EQS Group AG · Medacta Group
    Medacta Group SA reports strong revenue growth at 21.4% at constant currency and adjusted EBITDA margin at 28.2% in the first semester 2023
    22.09.23 · EQS Group AG · Medacta Group

    Ad-hoc Nachrichten

    Medacta Group SA Achieves 19.5% Revenue Growth, 27.9% EBITDA Margin in FY 2023
    13.03.24 · wO Newsflash · Medacta Group
    Medacta Group SA: Medacta Group SA reports robust revenue growth of 19.5% at constant currency and adjusted EBITDA1 margin 26.3%, or 27.9% at constant currency in FY 2023
    13.03.24 · EQS Group AG · Medacta Group